Bio-Medical Applications Of Tennessee, Inc. in Memphis, Tennessee - Dialysis Center

Bio-Medical Applications Of Tennessee, Inc. is a medicare approved dialysis facility center in Memphis, Tennessee and it has 13 dialysis stations. It is located in Shelby county at 6055 Primacy Parkway, Memphis, TN, 38119. You can reach out to the office of Bio-Medical Applications Of Tennessee, Inc. at (901) 681-4010. This dialysis clinic is managed and/or owned by Fresenius Medical Care. Bio-Medical Applications Of Tennessee, Inc. has the following ownership type - Profit. It was first certified by medicare in October, 2012. The medicare id for this facility is 442718 and it accepts patients under medicare ESRD program.

Dialysis Center Profile

NameBio-Medical Applications Of Tennessee, Inc.
Location6055 Primacy Parkway, Memphis, Tennessee
No. of Dialysis Stations 13
Medicare ID442718
Managed ByFresenius Medical Care
Ownership TypeProfit
Late Shifts No

Contact Information


6055 Primacy Parkway, Memphis, Tennessee, 38119
(901) 681-4010

Map and Direction



NPI Associated with this Dialysis Facility:

Dialysis Facilities may have multiple NPI numbers. We have found possible NPI number/s associated with Bio-Medical Applications Of Tennessee, Inc. from NPPES records by matching pattern on the basis of name, address, phone number etc. Please use this information accordingly.

NPI Number1659744555
Organization NameFresenius Medical Care Raleigh Bartlett
Doing Business AsBio-medical Applications Of Tennessee, Inc.
Address5020 English Towne Drive Memphis, Tennessee, 38128
Phone Number(901) 266-1551

NPI Number1922372572
Organization NameFresenius Medical Care Ridgeway.
Doing Business AsBio-medical Applications Of Tennessee Inc.
Address6055 Primacy Pkwy Memphis, Tennessee, 38119
Phone Number(901) 433-4503

Patient Distribution

Anemia Management

Dialysis patients with Hemoglobin data22
Medicare patients who had average hemoglobin (hgb) less than 10 g/dL32

Dialysis Adequacy

Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.

  • Hemodialysis
    Adult patients getting regular hemodialysis at the center47
    Adult patient months included in Kt/V greater than or equal to 1.2481
    Percentage of adult patients getting regular hemodialysis at the center98
    Percentage of pediatric patients getting regular hemodialysis at the center

Mineral and Bone Disorder

An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at Bio-Medical Applications Of Tennessee, Inc. with elevated calcium levels.

Patients with hypercalcemia53
Hypercalcemia patient months543
Patients with Serumphosphor55
Patients with Serumphosphor less than 3.5 mg/dL7
Patients with Serumphosphor from 3.5 to 4.5 mg/dL22
Patients with Serumphosphor from 4.6 to 5.5 mg/dL28
Patients with Serumphosphor from 5.6 to 7 mg/dL27
Patients with Serumphosphor greater than 7 mg/dL16

Vascular Access

The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.

Patients included in arterial venous fistula and catheter summaries 45
Patient months included in arterial venous fistula and catheter summaries 387
Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment70
Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer18

Hospitalization Rate

The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.

Standard Hospitalization Summary Ratio(SHR) YearJanuary, 2016 - December, 2016
Patients in facility's Hospitalization Summary49
Hospitalization Rate in facility158.7 (As Expected)
Hospitalization Rate: Upper Confidence Limit310.6
Hospitalization Rate: Lower Confidence Limit85

Readmission Rate

The rate of readmission show you whether patients who were being treated regularly at Bio-Medical Applications Of Tennessee, Inc. were readmitted more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other dialysis centers.

Standard Readmission Summary Ratio(SRR) YearJanuary, 2016 - December, 2016
Readmission Rate in facility36.8 (As Expected)
Readmission Rate: Upper Confidence Limit48.3
Readmission Rate: Lower Confidence Limit26.3

Infection Rate

Hemodialysis treatment requires direct access to the bloodstream, which can be an opportunity for germs to enter the body and cause infection. This information shows how often patients at Bio-Medical Applications Of Tennessee, Inc. get infections in their blood each year compared to the number of infections expected for the center based on the national average.

Standard Infection Summary Ratio(SIR) YearJanuary, 2016 - December, 2016
Infection Rate in facility.25 (As Expected)
SIR: Upper Confidence Limit1.25
SIR: Lower Confidence Limit.01

Transfusion Summary

Patients with anemia require blood transfusions if their anemia is not managed well by their dialysis center. This information shows whether Bio-Medical Applications Of Tennessee, Inc.'s rate of transfusions is better than expected, as expected, or worse than expected, compared to other centers that treat similar patients.

Standard Transfusion Summary Ratio (STrR) Year January, 2016 - December, 2016
Patients in facility's Transfusion Summary 43
Transfusion Rate in facility90 (Worse than Expected)
Transfusion Rate: Upper Confidence Limit202.4
Transfusion Rate: Lower Confidence Limit44.2

Survival Summary

The rate of mortality show you whether patients who were being treated regularly at Bio-Medical Applications Of Tennessee, Inc. lived longer than expected (better than expected), don’t live as long as expected (worse than expected), or lived as long as expected (as expected), compared to similar patients treated at other facilities.

Standard Survival Summary Ratio(SIR) YearJanuary, 2013 - December, 2016
Patients in facility's Survival Summary185
Mortality Rate in facility19.3 (As Expected)
Mortality Rate: Upper Confidence Limit30.6
Mortality Rate: Lower Confidence Limit11.5

Dialysis Facility in Memphis, TN

FMC East Memphis
Location: 6490 Mt. Moriah Ext., Memphis, Tennessee, 38115
Phone: (901) 367-1001
FMC Memphis
Location: 1428 Monroe Avenue, Memphis, Tennessee, 38104
Phone: (901) 272-8683
Memphis Central Dialysis
Location: 889 Dr. M. L. King Jr. Ave, Memphis, Tennessee, 38126
Phone: (901) 525-1719
Memphis East Dialysis
Location: 50 Humphreys Blvd Ste 42, Memphis, Tennessee, 38120
Phone: (901) 747-2316
FMC Graceland
Location: 1200 Farrow Street, Memphis, Tennessee, 38116
Phone: (901) 398-1163

Medicare Program: Medicare is a federal government program which provides health insurance to people who are 65 or older. This program also covers certain younger people with disabilities (who receive Social Security Disability Insurance - SSDI), and people with End-Stage Renal Disease (permanent kidney failure requiring dialysis or a transplant, sometimes called ESRD.

Medicare Assignment: Assignment means that your doctor, provider, or supplier agrees (or is required by law) to accept the Medicare-approved amount as full payment for covered services. Most doctors, providers, and suppliers accept assignment, but you should always check to make sure. Participating providers have signed an agreement to accept assignment for all Medicare-covered services.

NPI Number: The National Provider Identifier (NPI) is a unique identification number for covered health care providers. The NPI must be used in lieu of legacy provider identifiers in the HIPAA standards transactions. Covered health care providers and all health plans and health care clearinghouses must use the NPIs in the administrative and financial transactions adopted under HIPAA (Health Insurance Portability and Accountability Act).

Our Data: Information on www.medicarelist.com is built using data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA). The information disclosed on the NPI Registry are FOIA-disclosable and are required to be disclosed under the FOIA and the eFOIA amendments to the FOIA. There is no way to 'opt out' or 'suppress' the NPPES record data for health care providers with active NPIs.